Plastic Surgeon Reports Early Success with New Non-Opioid Pain Medication
Plastic surgeon Dr. Gary Lawton is reporting encouraging early clinical experience with JOURNAVX®, a new non-opioid pain medication. The drug is being used as part of advanced multimodal recovery protocols for cosmetic surgery patients.
San Antonio, TX – Plastic surgeon Dr. Gary Lawton has initiated the use of JOURNAVX®, a novel non-opioid pain medication, as part of advanced multimodal recovery protocols for his cosmetic surgery patients. With over 25 years in practice and tens of thousands of breast and body procedures performed, Lawton reports encouraging early clinical outcomes.
The integration of JOURNAVX® into post-operative care aims to provide effective pain management while minimizing the reliance on traditional opioid-based treatments. This multimodal approach intends to enhance patient recovery and mitigate potential side effects associated with opioid use.
Lawton has reportedly observed positive patient responses in terms of pain relief, without the typical opioid-related adverse effects such as nausea or constipation. However, further comprehensive clinical data and studies are necessary to fully validate the medication’s efficacy and safety profile within the field of plastic surgery.
The introduction of JOURNAVX® reflects ongoing efforts within the medical community to identify safer and more effective pain management solutions for post-surgical patients. Future steps may involve broader clinical validation and regulatory approvals before widespread adoption can occur.